DYADIC INTERNATIONAL INC Earnings Per Share, Basic and Diluted
DYADIC INTERNATIONAL INC (DYAI) reported Earnings Per Share, Basic and Diluted of -$0.47 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-29
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.15.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.06.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.14.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.12.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for fiscal 2021 was -$0.47.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for fiscal 2020 was -$0.34.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for fiscal 2019 was -$0.31.
- DYADIC INTERNATIONAL INC earnings per share, basic and diluted for fiscal 2018 was -$0.21.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.47 10-K · filed 2022-03-29 |
| 2021-09-30 | -$0.06 10-Q · filed 2021-11-10 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.32 10-Q · filed 2021-11-10 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.14 10-Q · filed 2021-08-12 | -$0.26 10-Q · filed 2021-08-12 | -$0.33 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.42 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-03-31 | -$0.12 10-Q · filed 2021-05-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.28 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$0.38 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2020-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.34 10-K · filed 2022-03-29 |
| 2020-09-30 | -$0.09 10-Q · filed 2021-11-10 | -$0.19 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.27 10-Q · filed 2021-11-10 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-06-30 | -$0.10 10-Q · filed 2021-08-12 | -$0.18 10-Q · filed 2021-08-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.30 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-03-31 | -$0.08 10-Q · filed 2021-05-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.31 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2019-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.23 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.31 10-K · filed 2021-03-30 |
| 2019-09-30 | -$0.06 10-Q · filed 2020-11-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.24 10-Q · filed 2020-11-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2020-11-12 |
| 2019-06-30 | -$0.10 10-Q · filed 2020-08-13 | -$0.18 10-Q · filed 2020-08-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.26 derived: net income ÷ weighted average shares · filed 2020-11-12 |
| 2019-03-31 | -$0.08 10-Q · filed 2020-05-14 | -$0.10 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-11-12 |
| 2018-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.08 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.21 10-K · filed 2020-03-30 |
| 2018-09-30 | -$0.06 10-Q · filed 2019-11-13 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-11-13 | -$0.19 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$0.06 10-Q · filed 2019-08-13 | -$0.13 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$0.07 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$0.07 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |